Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea · Delayed Price · Currency is KRW 8,150.00
+200.00 (2.52%)
At close: Jan 23, 2026
Ahn-Gook Pharmaceutical Revenue
Ahn-Gook Pharmaceutical had revenue of 77.69B KRW in the quarter ending September 30, 2025, with 15.08% growth. This brings the company's revenue in the last twelve months to 300.96B, up 13.73% year-over-year. In the year 2024, Ahn-Gook Pharmaceutical had annual revenue of 271.12B with 16.02% growth.
Revenue (ttm)
300.96B
Revenue Growth
+13.73%
P/S Ratio
0.31
Revenue / Employee
769.71M
Employees
391
Market Cap
92.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 271.12B | 37.44B | 16.02% |
| Dec 31, 2023 | 233.68B | 28.29B | 13.77% |
| Dec 31, 2022 | 205.39B | 41.85B | 25.59% |
| Dec 31, 2021 | 163.53B | 20.17B | 14.07% |
| Dec 31, 2020 | 143.36B | -12.49B | -8.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| H.PIO | 257.56B |
| Daehan Nupharm | 201.59B |
| HYUNDAI BIOLAND | 129.68B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| Sam-A Pharm. | 76.66B |
| High Tech Pharm | 75.60B |